About the Program
CJI's Roadside Oral Fluid Program was created in December 2020 as part of the “Great Lakes, High Stakes” project, in partnership with the National Highway Traffic Safety Administration’s Region 5 Office. The program aims to address the growing concern of drug-impaired driving on Indiana roadways.
Through the agency's Traffic Safety Division, CJI is equipping law enforcement officers with roadside oral fluid devices to support in the detection of drug-impaired drivers.
These handheld analyzers use an oral fluid swab to detect the presence of six kinds of drugs: cocaine, methamphetamine, opiates, cannabis (THC), amphetamine and benzodiazepines. Similar to a portable breathalyzer, the device analyzes oral fluid for the presence of drugs in suspected impaired drivers.
Since the program’s launch in 2020, approximately 70 devices were initially distributed across the state. As of 2025, CJI has expanded distribution to over 200 devices, now supporting approximately 110 law enforcement agencies in the fight against drug-impaired driving.